{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:21:10Z","timestamp":1788916870042,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jvir.2024.03.025","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:09:02Z","timestamp":1711472942000},"page":"998-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes in Patients with Macrotrabecular-Massive Subtype Hepatocellular Carcinoma Treated with Yttrium-90 Transarterial Radioembolization"],"prefix":"10.1016","volume":"35","author":[{"given":"Huseyin Tugsan","family":"Balli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat Can","family":"Piskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-2312","authenticated-orcid":false,"given":"Sinan","family":"Sozutok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kivilcim Eren","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-6492","authenticated-orcid":false,"given":"Kairgeldy","family":"Aikimbaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.03.025_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2024.03.025_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jvir.2024.03.025_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2024.03.025_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.prp.2017.03.002","article-title":"Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasion","volume":"213","author":"Zhou","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jvir.2024.03.025_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jvir.2024.03.025_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11604-019-00817-3","article-title":"Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma","volume":"37","author":"Yoneda","year":"2019","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.jvir.2024.03.025_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2021.04.008","article-title":"Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?","volume":"113","author":"Kumar","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jvir.2024.03.025_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.03.025_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001289","article-title":"Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma","volume":"43","author":"Jeon","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jvir.2024.03.025_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2024.03.025_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00270-013-0600-8","article-title":"Standards of practice in transarterial radioembolization","volume":"36","author":"Mahnken","year":"2013","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.03.025_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2024.03.025_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","article-title":"CIRSE Quality Assurance Document and Standards for Classification of Complications: the CIRSE Classification System","volume":"40","author":"Filippiadis","year":"2017","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.03.025_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/JHC.S364742","article-title":"Macrotrabecular-massive hepatocellular carcinoma: what should we know?","volume":"9","author":"Li","year":"2022","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jvir.2024.03.025_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ebiom.2019.03.022","article-title":"Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma","volume":"42","author":"Long","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jvir.2024.03.025_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-016-0478-9","article-title":"FGF19\/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib","volume":"36","author":"Gao","year":"2017","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jvir.2024.03.025_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiol.2021203614","article-title":"Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma","volume":"300","author":"Feng","year":"2021","journal-title":"Radiology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T08:37:51Z","timestamp":1718959071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1051044324002641"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.03.025","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in Patients with Macrotrabecular-Massive Subtype Hepatocellular Carcinoma Treated with Yttrium-90 Transarterial Radioembolization","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}